INFLUENZA IMMUNIZATION
Clinical trials for INFLUENZA IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA IMMUNIZATION trials appear
Sign up with your email to follow new studies for INFLUENZA IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of mRNA flu shot shows promise
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested the safety and immune response of a new mRNA-based flu vaccine in healthy adults. Researchers gave 233 participants different dose levels of the experimental vaccine and monitored them for side effects and antibody production for a year. The goal was…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test double vaccine punch for seniors
⭐️ VACCINE ⭐️ CompletedThis study looked at whether it's safe and effective to give a high-dose flu shot and a Moderna COVID-19 booster shot at the same time to adults aged 65 and older. Researchers compared giving both shots together versus giving them separately. They measured side effects and how we…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:40 UTC
-
Supercharged flu shot for seniors shows promise in major trial
⭐️ VACCINE ⭐️ CompletedThis study tested whether a high-dose flu vaccine works better than the standard-dose vaccine for people aged 60 and older. Over 1,500 healthy volunteers received either the stronger shot or the regular one. Researchers measured the body's immune response and tracked side effects…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:38 UTC
-
Stronger flu shot for seniors? japanese trial compares doses and delivery
⭐️ VACCINE ⭐️ CompletedThis study tested if a high-dose flu shot given as a muscle injection works better than a standard-dose shot given under the skin for people aged 60 and older in Japan. It involved 2,100 healthy volunteers and measured their immune response and safety 28 days after vaccination. T…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 25, 2026 14:08 UTC
-
New flu shot shows strong immune response in kids and adults
⭐️ VACCINE ⭐️ CompletedThis study tested a new type of flu vaccine made using recombinant technology in people aged 9 to 49. The main goal was to see if the vaccine triggered a strong immune response in children and teens that was at least as good as the response in adults. Researchers also closely mon…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 18, 2026 18:25 UTC
-
First human tests for mRNA flu shot begin
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested the safety and immune response of a new mRNA flu vaccine in healthy adults. Researchers gave 159 participants one of several different doses of the experimental vaccine or a standard flu shot to compare. The main goal was to see if the new vaccine wa…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 17, 2026 12:55 UTC
-
Massive survey reveals Who's getting the flu shot in germany
Knowledge-focused CompletedThis study aimed to find out how many people in Germany were getting their seasonal flu vaccine. Researchers surveyed 5,000 adults, with a focus on people aged 60 and older, to get up-to-date information. The goal was to provide data to help public health officials and doctors en…
Matched conditions: INFLUENZA IMMUNIZATION
Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Knowledge-focused
Last updated Apr 01, 2026 23:26 UTC
-
Scientists collect blood after flu shots to predict next Year's strains
Knowledge-focused CompletedThis study collected blood samples from children (6 months to 9 years) and older adults (65+) after they received their annual flu vaccines. Researchers analyzed these samples to measure how well the body's immune system responded to the 2021-2022 vaccine formulas. The data helps…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE4 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists collect blood to build better flu shots
Knowledge-focused CompletedThis study collected blood samples from 90 healthy children (6 months to 9 years) and seniors (65+) who received standard flu vaccines. Researchers took blood before and after vaccination to analyze immune responses. The samples were sent to major health agencies to help them des…
Matched conditions: INFLUENZA IMMUNIZATION
Phase: PHASE4 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC